Puma Biotechnology, Inc. (PBYI)
9.78
-0.04
(-0.41%)
USD |
NASDAQ |
Sep 29, 16:00
9.78
0.00 (0.00%)
After-Hours: 20:00
Puma Biotechnology Price : 9.78 for Sept. 29, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 28, 2026 | 9.77 | 9.885 | 9.54 | 9.82 | 245941.0 |
| Sep 25, 2026 | 9.90 | 9.90 | 9.65 | 9.77 | 262070.0 |
| Sep 24, 2026 | 9.25 | 9.87 | 9.02 | 9.82 | 467561.0 |
| Sep 23, 2026 | 9.82 | 9.90 | 9.08 | 9.28 | 475938.0 |
| Sep 22, 2026 | 9.65 | 9.98 | 9.57 | 9.82 | 360724.0 |
| Sep 21, 2026 | 9.66 | 9.75 | 9.512 | 9.59 | 217570.0 |
| Sep 18, 2026 | 9.52 | 9.66 | 9.44 | 9.60 | 327066.0 |
| Sep 17, 2026 | 9.39 | 9.61 | 9.39 | 9.52 | 206156.0 |
| Sep 16, 2026 | 9.26 | 9.40 | 9.16 | 9.39 | 188832.0 |
| Sep 15, 2026 | 9.15 | 9.389 | 9.05 | 9.25 | 309922.0 |
| Sep 14, 2026 | 9.10 | 9.23 | 9.03 | 9.14 | 256653.0 |
| Sep 11, 2026 | 9.26 | 9.281 | 8.93 | 9.12 | 305140.0 |
| Sep 10, 2026 | 9.01 | 9.22 | 8.90 | 9.17 | 173459.0 |
| Sep 09, 2026 | 9.31 | 9.446 | 9.01 | 9.05 | 453608.0 |
| Sep 08, 2026 | 9.25 | 9.57 | 8.85 | 9.39 | 365782.0 |
| Sep 04, 2026 | 9.40 | 9.637 | 9.305 | 9.55 | 185912.0 |
| Sep 03, 2026 | 9.72 | 9.72 | 9.37 | 9.41 | 244320.0 |
| Sep 02, 2026 | 9.40 | 9.735 | 9.28 | 9.69 | 411940.0 |
| Sep 01, 2026 | 9.11 | 9.59 | 9.11 | 9.35 | 458304.0 |
| Aug 31, 2026 | 9.02 | 9.20 | 8.78 | 9.11 | 242883.0 |
| Aug 28, 2026 | 9.24 | 9.26 | 9.02 | 9.06 | 235040.0 |
| Aug 27, 2026 | 9.01 | 9.30 | 8.95 | 9.24 | 202716.0 |
| Aug 26, 2026 | 9.31 | 9.31 | 9.04 | 9.16 | 374470.0 |
| Aug 25, 2026 | 9.22 | 9.38 | 9.17 | 9.32 | 303444.0 |
| Aug 24, 2026 | 9.30 | 9.30 | 8.99 | 9.12 | 266136.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Anika Therapeutics, Inc. | 19.96 |
| Arcutis Biotherapeutics, Inc. | 26.76 |
| ACADIA Pharmaceuticals, Inc. | 20.22 |
| Alnylam Pharmaceuticals, Inc. | 254.20 |
| Savara, Inc. | 5.09 |
Price Related Metrics
| PE Ratio | 18.94 |
| PS Ratio | 2.177 |
| Price to Book Value | 3.607 |
| Price to Free Cash Flow | 12.23 |
| Earnings Yield | 5.28% |
| Market Cap | 499.78M |
| Operating PE Ratio | 16.54 |
| Normalized PE Ratio | 18.94 |